Clinical Study for the Efficacy and Safety of Anlotinib Combined with Docetaxel in the Second Line and above Treatment of Advanced Non-squamous Non-small Cell Lung Cancer
Latest Information Update: 03 Oct 2019
At a glance
- Drugs Catequentinib (Primary) ; Docetaxel (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 03 Oct 2019 New trial record